What one share of Evolus holds
We are a global performance beauty company delivering breakthrough products with a customer-centric approach. Our primary market is the cash-pay aesthetic market, which consists of medical products that consumers pay for directly out of pocket.
Evolus’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.86 |
|---|---|
| Profit | −$0.53 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | −$0.28 |
| Cash and investments | $0.68 |
| Debt | $2.37 |
| Book value | −$0.47 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | — | −$0.27 | $0.00 | −$0.80 | — | −$4.57 |
| 2018 | $0.00 | −$1.92 | $0.00 | −$1.05 | — | $3.09 |
| 2019 | $1.24 | −$3.19 | $0.01 | −$3.32 | — | $2.37 |
| 2020 | $1.68 | −$4.83 | $0.02 | −$1.74 | — | −$2.16 |
| 2021 | $2.00 | −$0.94 | $0.01 | −$0.68 | — | $1.47 |
| 2022 | $2.65 | −$1.33 | $0.03 | −$1.54 | — | $0.33 |
| 2023 | $3.55 | −$1.08 | $0.01 | −$0.61 | — | −$0.36 |
| 2024 | $4.29 | −$0.81 | $0.02 | −$0.31 | — | $0.09 |
| 2025 | $4.61 | −$0.80 | $0.05 | −$0.71 | — | −$0.36 |
Common questions about Evolus
How much does one share of Evolus earn?
Over the last 12 months, Evolus lost $0.53 for each share on $4.86 of sales.
Does Evolus pay a dividend?
Evolus didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Evolus’s book value per share?
Evolus’s book value is negative (−$0.47 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Evolus have?
Each share of Evolus has $0.68 of cash and investments and $2.37 of debt, as of June 30, 2026.
What is Evolus’s free cash flow per share?
−$0.28 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Evolus bought back shares?
Evolus’s share count rose about 290% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.